| Nome |
# |
|
Transformed follicular lymphoma, file e31e124d-2acf-987f-e053-3705fe0a095a
|
3.564
|
|
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL), file e31e124e-5732-987f-e053-3705fe0a095a
|
755
|
|
R-CVP versus R-CHOP versus R-FM for the initial treatment of patients with advanced-stage follicular lmphoma: results of the FOLL05 trial conducted by the Fondazione Italiana Linfomi, file e31e124b-35f7-987f-e053-3705fe0a095a
|
745
|
|
Nursing role in the assessment and care of hepatic sinusoidal obstruction syndrome patients: a consensus paper by the “Gruppo Italiano Trapianto di Midollo Osseo”, file e31e124e-7792-987f-e053-3705fe0a095a
|
678
|
|
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi, file e31e124d-23c0-987f-e053-3705fe0a095a
|
669
|
|
Bendamustine in combination with gemcitabine and vinorelbine is an effective regimen as induction chemotherapy before autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma: Final results of a multicenter phase II study, file e31e124b-e147-987f-e053-3705fe0a095a
|
624
|
|
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma, file e31e124d-248f-987f-e053-3705fe0a095a
|
609
|
|
The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study, file e31e124d-8278-987f-e053-3705fe0a095a
|
481
|
|
A multicenter retrospective clinical study of CD5/CD10-negative chronic B cell leukemias., file e31e124c-142a-987f-e053-3705fe0a095a
|
361
|
|
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma, file e31e124d-28a9-987f-e053-3705fe0a095a
|
346
|
|
Survival of cancer patients in Italy [La sopravvivenza dei pazienti oncologici in Italia [La sopravvivenza dei pazienti oncologici in Italia], file e31e124d-809b-987f-e053-3705fe0a095a
|
327
|
|
ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia, file e31e124b-e0c8-987f-e053-3705fe0a095a
|
287
|
|
Positron-emission tomography–based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma, file e31e124e-572e-987f-e053-3705fe0a095a
|
241
|
|
Texture analysis and multiple-instance learning for the classification of malignant lymphomas, file e31e124e-7790-987f-e053-3705fe0a095a
|
240
|
|
Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: The FIL FOLL05 trial, file e31e124b-ecdf-987f-e053-3705fe0a095a
|
233
|
|
A Gene Expression–based Model to Predict Metabolic Response after Two Courses of ABVD in Hodgkin Lymphoma Patients, file e31e124e-572c-987f-e053-3705fe0a095a
|
229
|
|
The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi, file e31e124b-2fa6-987f-e053-3705fe0a095a
|
223
|
|
Brentuximab vedotin followed by ABVD +/- radiotherapy in patients with previously untreated Hodgkin lymphoma: final results of a pilot phase II study, file e31e124b-f0fd-987f-e053-3705fe0a095a
|
217
|
|
The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL), file e31e124b-29b3-987f-e053-3705fe0a095a
|
213
|
|
Novel prognostic tools that identify high-risk follicular lymphoma, file e31e124e-a066-987f-e053-3705fe0a095a
|
213
|
|
Personalised approach in follicular lymphoma, file e31e124e-a1d5-987f-e053-3705fe0a095a
|
212
|
|
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience, file e31e124f-fd01-987f-e053-3705fe0a095a
|
211
|
|
Splenosis peritonei., file e31e124c-3951-987f-e053-3705fe0a095a
|
210
|
|
Reply to T.P. Vassilakopoulos et al, file e31e124b-d07d-987f-e053-3705fe0a095a
|
209
|
|
Veno-occlusive disease nurse management: Development of a dynamic monitoring tool by the GITMO nursing group, file e31e124b-e0c6-987f-e053-3705fe0a095a
|
209
|
|
ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial, file e31e124c-4e4f-987f-e053-3705fe0a095a
|
205
|
|
Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi, file e31e124b-d98f-987f-e053-3705fe0a095a
|
201
|
|
A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma, file e31e124b-3166-987f-e053-3705fe0a095a
|
198
|
|
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: A systematic review and meta-analysis of randomized clinical trials, file e31e124d-2039-987f-e053-3705fe0a095a
|
195
|
|
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL), file e31e124c-38be-987f-e053-3705fe0a095a
|
188
|
|
Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study, file e31e1250-848f-987f-e053-3705fe0a095a
|
188
|
|
High-dose therapy and autologous stem cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy: long-term results., file e31e124c-115e-987f-e053-3705fe0a095a
|
186
|
|
ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study., file e31e124c-1495-987f-e053-3705fe0a095a
|
177
|
|
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma, file e31e124c-16e4-987f-e053-3705fe0a095a
|
176
|
|
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study, file e31e124e-483a-987f-e053-3705fe0a095a
|
175
|
|
Adapted treatment guided by interim PET-CT scan in advanced Hodgkin's lymphoma, file e31e124b-a985-987f-e053-3705fe0a095a
|
173
|
|
Case studies of elderly patients with non-Hodgkin's lymphoma., file e31e124b-1b18-987f-e053-3705fe0a095a
|
171
|
|
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL study, file e31e124b-b234-987f-e053-3705fe0a095a
|
171
|
|
Anthracyclines: a cornerstone in the management of non-Hodgkin's lymphoma., file e31e124b-2138-987f-e053-3705fe0a095a
|
162
|
|
The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study, file e31e124d-8277-987f-e053-3705fe0a095a
|
147
|
|
Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: A 16-year follow-up study, file e31e124d-5414-987f-e053-3705fe0a095a
|
138
|
|
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi, file e31e124c-3900-987f-e053-3705fe0a095a
|
134
|
|
Fertility in female survivors of hodgkin's lymphoma., file e31e124b-1d5e-987f-e053-3705fe0a095a
|
133
|
|
Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma, file e31e124f-3aee-987f-e053-3705fe0a095a
|
126
|
|
Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project, file e31e124d-f79e-987f-e053-3705fe0a095a
|
124
|
|
Rituximab plus bendamustine as front-line treatment in frail elderly ( extgreater70 years) patients with diffuse large b-cell non-hodgkin lymphoma: A phase ii multicenter study of the fondazione italiana linfomi, file e31e124e-a1d6-987f-e053-3705fe0a095a
|
123
|
|
Follicular Lymphoma - treatment and prognostic factors., file e31e124b-277f-987f-e053-3705fe0a095a
|
120
|
|
Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study., file e31e124a-9db9-987f-e053-3705fe0a095a
|
119
|
|
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale, file e31e124d-fd7a-987f-e053-3705fe0a095a
|
118
|
|
A B-cell receptor-related gene signature predicts survival in mantle cell lymphoma: Results from the Fondazione Italiana Linfomi MCL-0208 trial, file e31e124e-a1d4-987f-e053-3705fe0a095a
|
117
|
|
Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi, file e31e124e-5730-987f-e053-3705fe0a095a
|
113
|
|
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease, file e31e124a-959b-987f-e053-3705fe0a095a
|
109
|
|
Prognostic assessment in patients with indolent B-cell lymphomas, file e31e124e-0aa4-987f-e053-3705fe0a095a
|
107
|
|
Brentuximab vedotin in relapsed/refractory Hodgkin's lymphoma: the Italian experience and results of its use in daily clinical practice outside clinical trials, file e31e124e-0069-987f-e053-3705fe0a095a
|
102
|
|
Age-adjusted international prognostic index is a predictor of survival in gastric diffuse B-cell non-Hodgkin lymphoma patients, file e31e124e-1873-987f-e053-3705fe0a095a
|
95
|
|
T-cell lymphoma in South America and Europe., file e31e124b-2a23-987f-e053-3705fe0a095a
|
94
|
|
Do we need high-dose therapy for initial treatment of high-risk Hodgkin's disease? Venezia New isights in Hematology, file e31e124c-3a27-987f-e053-3705fe0a095a
|
80
|
|
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic study, file 84411743-c4b8-4bf3-b9e3-d4b2c5c0efd7
|
74
|
|
Durable remission in a patient with leptomeningeal relapse of a MYC/BCL6-positive double-hit DLBCL treated with lenalidomide monotherapy, file e31e124b-ca4b-987f-e053-3705fe0a095a
|
66
|
|
Indolent t-cell lymphoproliferative disorders of the gastrointestinal tract (Itlpd-gi): A review, file b50ec742-57ce-4403-b072-69056c2fafa4
|
52
|
|
Nonpeghylated liposomal doxorubicin combination regimen (R-COMP) for the treatment of lymphoma patients with advanced age or cardiac comorbidity, file 9477b05d-d18e-41bd-b08a-085e272c5b07
|
37
|
|
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020, file 7502313b-e415-4b42-bd83-25da33647560
|
31
|
|
High-risk follicular lymphoma patients: Identification and treatment, file e31e124e-a1d8-987f-e053-3705fe0a095a
|
31
|
|
Survival and Recurrence in Vitreoretinal Lymphoma Simulating Uveitis at Presentation: The Possible Role of Combined Chemotherapy, file 3bd365f3-16a3-4fc5-b920-eb5415c2023d
|
25
|
|
ALK-negative anaplastic large cell lymphoma: Features and outcomes of 235 patients from the International T-Cell Project, file b6b46859-883b-42f2-a5d8-507c5d245a2f
|
24
|
|
Utility of baseline 18FDG-PET/CT functional parameters in defining prognosis of primary mediastinal (thymic) large B-cell lymphoma, file e31e124f-24fa-987f-e053-3705fe0a095a
|
21
|
|
What's new in peripheral T-cell lymphomas, file a35ff483-12ab-40bf-983b-37dc348903e6
|
17
|
|
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma, file 29880481-a7d6-4868-aada-8920f00e3814
|
13
|
|
Prevalence and prognostic significance of sMUC-1 levels in plasma cell dyscrasias, file e31e124a-94bb-987f-e053-3705fe0a095a
|
13
|
|
Prognostic Impact of Muscle Quantity and Quality and Fat Distribution in Diffuse Large B-Cell Lymphoma Patients, file 5bdc4c94-3bd5-4b41-ba57-fe4a987eb956
|
11
|
|
Early palliative care versus standard care in haematologic cancer patients at their last active treatment: Study protocol of a feasibility trial, file 5cb0a6f9-a99b-437b-b012-abd616974398
|
11
|
|
Management of patients with lymphoma and COVID-19: Narrative review and evidence-based practical recommendations, file 30d194d3-4825-4db3-84d0-e568784e8318
|
10
|
|
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi, file 4e37edcf-a376-4ce0-acff-b865b384aa3e
|
9
|
|
An international analysis evaluating frontline bendamustine with rituximab in extranodal marginal zone lymphoma, file 5a57bc63-592f-4ab4-82ec-694db8826ccc
|
9
|
|
Allogeneic stem cell transplantation in mantle cell lymphoma in the era of new drugs and CAR-T cell therapy, file 76ccb271-f0cf-405b-9c27-36916502ccd9
|
9
|
|
PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study, file e31e1250-52a5-987f-e053-3705fe0a095a
|
9
|
|
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi, file 32ec5fee-f5a4-4163-8dba-2b391e07857c
|
8
|
|
Follicular Lymphoma International Prognostic Index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project, file e31e124a-a056-987f-e053-3705fe0a095a
|
8
|
|
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi, file 34b384bb-c327-4b71-a791-1ed96e392075
|
6
|
|
ABVD Compared With BEACOPP Compared With CEC for the Initial Treatment of Patients With Advanced Hodgkin's Lymphoma: Results From the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial., file e31e124a-9ebd-987f-e053-3705fe0a095a
|
6
|
|
Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial, file e31e124a-a124-987f-e053-3705fe0a095a
|
6
|
|
PET-CT for staging and early response: Results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study, file e31e124b-da38-987f-e053-3705fe0a095a
|
6
|
|
Outcome of frail elderly patients with diffuse large B-cell lymphoma prospectively identified by Comprehensive Geriatric Assessment: Results from a study of the Fondazione Italiana Linfomi, file 9b3b5786-75b1-422a-bf9b-a0958bf2f4af
|
5
|
|
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma, file a51c4ca8-fcec-4c42-9ad0-f8981fbd7c78
|
5
|
|
Pure red-cell aplasia and epoetin therapy, file e31e124a-94b0-987f-e053-3705fe0a095a
|
5
|
|
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL), file 4ec422a7-5fe6-41b5-8f41-f245f7b3f41c
|
4
|
|
Immune-related pan-cancer gene expression signatures of patient survival revealed by NanoString-based analyses, file 5f284faa-6993-4390-8227-3563a273cdce
|
4
|
|
Prognosis of follicular lymphomas, file e31e124a-954d-987f-e053-3705fe0a095a
|
4
|
|
Monocytosis has adverse prognostic significance and impacts survival in patients with T-cell lymphomas, file e31e124a-a923-987f-e053-3705fe0a095a
|
4
|
|
Watchful waiting in low-tumorburden follicular lymphoma in the Rituximab era. Results of a F2 observational, file e31e124a-af61-987f-e053-3705fe0a095a
|
4
|
|
Use of 2-(18F)fluoro-2-deoxy-D-glucose positron emission tomography in patients with Hodgkin lymphoma in daily practice: a population-based study from Northern Italy, file e31e124a-b088-987f-e053-3705fe0a095a
|
4
|
|
Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs, file e31e124e-a068-987f-e053-3705fe0a095a
|
4
|
|
Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: A matched cross-sectional study, file edc52614-73ac-4a1b-aae6-bf4cd6204b02
|
4
|
|
The First 2 Years of Biosimilar Epoetin for Cancer and Chemotherapy-Induced Anemia in the U.S.: A Review from the Southern Network on Adverse Reactions, file 2c76b305-d586-4112-8baa-7f4913a51c70
|
3
|
|
Prognostic tools for older patients with DLBCL: complex patients require complex solutions and a personal touch, file 3149c682-6f48-481a-a008-e4242ca7f1fb
|
3
|
|
Prognostic value of bone marrow tracer uptake pattern in baseline PET scans in hodgkin lymphoma: Results from an international collaborative study, file d3025462-7417-47c5-a47b-6ba14a99c750
|
3
|
|
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study., file e31e124a-9a0e-987f-e053-3705fe0a095a
|
3
|
|
Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy., file e31e124a-9dba-987f-e053-3705fe0a095a
|
3
|
|
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions., file e31e124a-a81d-987f-e053-3705fe0a095a
|
3
|
|
Clinicopathologic characteristics of angioimmunoblastics T-cell lymphoma (AITL): analysis of 243 cases from the International Peripheral T-cell Lymphoma Project., file e31e124a-af60-987f-e053-3705fe0a095a
|
3
|
| Totale |
17.551 |
